Clifford Chance

Clifford Chance advises 3i on its investment in Royal Sanders

Clifford Chance has advised private equity firm 3i on its investment in Royal Sanders, a leading European private label and contract manufacturing producer of personal care products with plants in the Netherlands (Vlijmen) and in the UK (Preston). 3i is investing alongside management to drive the company’s international growth strategy. The business is being purchased from Dutch private equity firm, Egeria. Royal Sanders’ main product categories include shampoo, bath and shower gels, body lotions and hand wash and its key geographies are the Benelux, Germany and UK. The company sells its products through private label, contract manufacturing and own brands including Van Gils, Sanicur and Odorex. Royal Sanders has some 350 employees and generates a turnover of around EUR 150 million. 

The Clifford Chance team that advised 3i was led by Greg Crookes and included Tim Heerschop, Marije Senne and Femke Buijs. Jelle Hofland and Boudewijn Vermeer advised 3i on obtaining debt financing for this transaction. Liesbeth Buiter and Sophie van Marwijk Kooij advised on environmental and real estate matters, Frans Muller and Jurre Jurriëns provided advice on compliance and antitrust matters, Floris van de Bult and Willemijn de Wit advised on the employment aspects of this transaction, Michiel Sunderman and Daan Smole advised on tax matters, Wijnanda Rutten advised on pension matters, Mark Jan Arends and Serkan Özel provided notarial assistance, Nadia Jagusiak and Shila Ruff advised on IP related matters and Esther Griffioen on hedging matters. 

The team assisting on due diligence consisted of lawyers from the Financial Markets Group and the Employment, IP, Pensions and Real Estate teams of Clifford Chance in Amsterdam and lawyers from Clifford Chance in London.